Early Investigator Advancement Program (EIAP)

Is EIAP Right for Me?

Review the following statements to see whether EIAP is for you (see full eligibility criteria below):

• I am a citizen or non-citizen national, or Permanent Resident of the United States.
• I am a researcher or clinician scientist from the extramural community.
• I have never been a PI or MPI on an NIH R01 or equivalent grant before.
• I am currently conducting cancer or cancer health disparity-related research.
• I hold a junior investigator position at my institution and qualify as an ESI or NI.
• My institution supports me in submitting an R01 application by October/November 2025.
• I am prepared to work toward and submit an R01 application by October/November 2025.
• The R01 that I am including in my EIAP application is not currently under review.
• I am able to participate in all program activities.

NCI values diversity and particularly encourages applicants from populations underrepresented in the cancer research workforce, as noted in the NIH’s Notice of Interest in Diversity (NOT-OD-20-031).

EIAP Selection Criteria

Individuals considered for the Scholar position are chosen based on their junior investigator status and the quality of their application materials. NCI will conduct administrative reviews of applications and will support meritorious applications submitted for consideration based on the following review criteria:

• Candidate Research Background and Training Potential 
• Institution Support
• Draft R01 Proposal
• Letters of Reference

Program Components

Scholars are expected to participate in the following virtual program components:

• A Grant Writing Workshop (2 half days with a free copy of Grantsmanship Workbook included)
• Individual consultations with a nationally renowned NIH grants expert
• Mentored Mock Review (MMR) session
• Engagement with a volunteer mentor
• Individualized consultation with EIAP team members
• Engagement with a grant writing expert to review and help refine the Scholar’s R01 in preparation for submission in October/November
• Career development workshops and webinars
• Continued engagement with EIAP team members beyond the Scholar’s program period to provide support in the Scholar’s path to success

Associates are expected to participate in the following virtual program components:

• A Grant Writing Workshop (2 half days with free copy of Grantsmanship Workbook included)
• Mentored Mock Review (MMR) session
• Career development workshops and webinars

The application period opens on October 1, 2024, and closes on November 1, 2024. Applicants should expect to be informed of their status based on the timeline below. The target start date is February 12, 2025.

Early Investigator Advancement Program 2024–2025 Timeline

The EIAP Experience

Build your grant preparation skills and prepare an R01 grant application! As an EIAP Scholar, you will be guided through the grant-writing process from drafting your Specific Aims section through submission. You will also gain important insights into the process of NIH review committees. To start the program, you will take part in a two, half-day grant writing virtual seminar. Then, you will participate in a hands-on workshop which includes individual meetings to review and revise the Specific Aims section of your application prior to submission. Your full R01 application draft will be reviewed by a grantsmanship expert, and you will receive detailed, written feedback. Finally, you will participate in a mock review to gain insight into how R01 applications are reviewed by an NIH review committee. Valuable examples of NIH-funded R01 applications, summary statements, sharing plans, leadership plans, and more can be accessed on the NIH Grants & Funding site.

Connect with mentors and grow your professional network! As an EIAP Scholar, you will have the opportunity to connect with multiple mentors, including established investigators, scientists in different sectors, as well as near-peer and peer mentors. Activities will be held for each EIAP cohort to encourage peer mentoring and community building.

Learn and grow through a professional and career development webinar series! EIAP scholars will have access to a series of focused webinars important to aspiring researchers. These webinars may include, for example, research priorities at NCI, components and key elements of a grant proposal, how to be a proactive mentee, establishing and growing a research group, post-award grant management, and other relevant topics.

Apply to EIAP

Application Requirements

To apply to EIAP, the following documents should be prepared. Fully completed applications are due by 11:59 p.m. (in your time zone) on November 1, 2024. 

To apply to EIAP, you should be prepared to address the following:

• Name
• Email address
• Current institution
• Statement that you are a citizen, non-citizen national, or legal permanent resident of the United States. Do not send documentation with your application.
• Statement indicating you have not previously received NIH R01 or equivalent funding as a Principal Investigator.
• Statement indicating preparedness to submit an R01 (which includes a draft R01) by October/November 2025 (see the "Draft R01" bullet below for full details).
• Statement indicating whether you are an Early Stage Investigator or New Investigator.
• Your immediate and long-term career goals.
• Cancer research type (i.e., basic, translational, behavioral/population, or clinical) and site (e.g., lung, brain, skin) if appropriate.
• If applicable, indicate if your research directly aims to impact cancer health disparities.
• Please let us know what you are looking for in a mentor (e.g., qualities, areas of research, etc.)
• Additional information you feel is relevant.

You will be asked to submit the following documents:

• Draft R01: Your draft R01 (as a separate PDF file) should include:
  • Project Summary/Abstract (1 page)
  • Specific Aims (1 page)
  • Research Strategy (no more than 12 pages including significance, innovation, approach, which includes research design, justification, and expected outcomes and/or impact)
  • Statement indicating plan to submit IRB approval, if applicable.
  • Bibliography

The R01 draft will be refined and prepared for submission to the NIH by October/ November 2025 according to prescribed NIH standards.

• Institution Letter: Each application must include a letter from the applicant institution leadership in support of your intentions to submit an R01 application by October/November 2025. This letter should include reference to support, equipment, and other physical resources available that will be adequate to support an R01 application. The letter should also provide a statement with regard to current mentoring support. Additionally, the letter must describe how the candidate furthers the goals of the program, consistent with applicable law and the Notice of NIH’s Interest in Diversity (NIH-OD-20-031). This letter must be on institutional letterhead and signed by an institutional official. Applications missing this letter will be considered incomplete.
• NIH Biosketch: Please refer to the NIH for guidance and an appropriate template.
• References: Provide two letters of reference from individuals who can comment on your potential as an R01 investigator. Letters should be on institutional letterhead and signed.

Apply for EIAP by clicking the link below. You will need to log in to the application system using your NIH eRA Commons ID. If you do not have an NIH eRA Commons ID, please contact Katelyn Garfinkel at EIAP@nih.gov and request one. Follow the instructions on the application page once you have logged into the application system. If you have any questions, please contact us at EIAP@nih.gov.

LINK TO EIAP APPLICATION

EIAP Eligibility

To be eligible for EIAP:

• Applicants must be citizens, non-citizen nationals or Permanent Residents of the United States.
• Applicants must be Early Stage Investigators (ESI) or New Investigators (NI) who are currently actively conducting cancer research or cancer-related research.
• Applicants have not previously competed successfully for NIH R01 or R01 equivalent funding.
• An applicant must be holding a current position at an institution that is eligible for an R01 application and is supportive of the applicant’s plans to submit an R01 application by October/November 2025.

NCI is particularly interested in encouraging applications from individuals who are from diverse backgrounds, including those who are from groups underrepresented in the cancer research workforce, for example those from the groups noted in the Notice of NIH’s Interest in Diversity (NOT-OD-20-031).

Other Considerations

NCI encourages applications from scientists who participated in the NCI Center for Cancer Health Equity (CCHE) Continuing Umbrella of Research Experiences (CURE), CCHE's Partnerships to Advance Cancer Health Equity (PACHE), NIH's National Research Mentoring Network, the NIH Building Infrastructure Leading to Diversity (BUILD) Initiative, and/or the NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program.

Contact

You are encouraged to pose your questions to EIAP program staff. Please contact Dan Eckstein and Dr. Maria Jamela (Jay) Revilleza at EIAP@nih.gov.